Customisable DNA array due in 1Q04
Acacia Research has said that its CombiMatrix unit will launch what it claims is the first fully-customisable DNA microarray platform, CustomArray, in the first quarter of 2004.
Acacia Research has said that its CombiMatrix unit will launch what it claims is the first fully-customisable DNA microarray platform, CustomArray, in the first quarter of 2004.
An international group of researchers has provided experimental evidence to suggest that the activity of a gene known as GAD2 is related to obesity.
China has become the first country in the world to grant a commercial license to a gene therapy medication. The new drug, called Gendicine, will be launched for the treatment of head and neck cancer in January.
Researchers in the USA have uncovered a cellular mechanism that could lead to a larger role for retinoids, compounds derived from vitamin A, in the treatment of cancer.